Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.

Expert review of pharmacoeconomics & outcomes research(2023)

引用 0|浏览3
暂无评分
摘要
Screening colonoscopy had the highest productivity loss and healthcare costs up-front, suggesting potential cost benefits for noninvasive screening modalities. The more frequent screening interval required for FIT and FOBT resulted in a higher yearly cost than colonoscopy or mt-sDNA.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要